NDC Code(s) : 0615-8485-39, 0615-8485-05, 0615-8485-30, 0615-8486-39, 0615-8486-05, 0615-8486-30, 0615-8487-39, 0615-8487-05, 0615-8487-30
Packager : NCS HealthCare of KY, LLC dba Vangard Labs

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Sertraline hydrochlorideSertraline hydrochloride TABLET, FILM COATED
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0615-8485(NDC:70010-203)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SERTRALINE HYDROCHLORIDE(UNII: UTI8907Y6X)
(SERTRALINE - UNII:QUC7NX6WMB) 		SERTRALINE25 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE(UNII: ETJ7Z6XBU4)
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS(UNII: L11K75P92J)
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED(UNII: 2165RE0K14)
MAGNESIUM STEARATE(UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE(UNII: OP1R32D61U)
SODIUM STARCH GLYCOLATE TYPE A(UNII: H8AV0SQX4D)
TALC(UNII: 7SEV7J4R1U)
HYPROMELLOSE 2910 (5 MPA.S)(UNII: R75537T0T4)
POLYETHYLENE GLYCOL 400(UNII: B697894SGQ)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
D&C YELLOW NO. 10(UNII: 35SW5USQ3G)
FERROSOFERRIC OXIDE(UNII: XM0M87F357)
FD&C BLUE NO. 2(UNII: L06K8R7DQK)
Product Characteristics
Color green Score 2 pieces
Shape CAPSULE Size 8 mm
Flavor Imprint Code G;74
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0615-8485-3930 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
2NDC:0615-8485-0515 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
3NDC:0615-8485-306 in 1 BOX, UNIT-DOSE 17/08/2023
35 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078403 05/15/2023
Sertraline hydrochlorideSertraline hydrochloride TABLET, FILM COATED
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0615-8486(NDC:70010-204)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SERTRALINE HYDROCHLORIDE(UNII: UTI8907Y6X)
(SERTRALINE - UNII:QUC7NX6WMB) 		SERTRALINE50 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE(UNII: ETJ7Z6XBU4)
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS(UNII: L11K75P92J)
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED(UNII: 2165RE0K14)
MAGNESIUM STEARATE(UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE(UNII: OP1R32D61U)
SODIUM STARCH GLYCOLATE TYPE A(UNII: H8AV0SQX4D)
TALC(UNII: 7SEV7J4R1U)
HYPROMELLOSE 2910 (5 MPA.S)(UNII: R75537T0T4)
POLYETHYLENE GLYCOL 400(UNII: B697894SGQ)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
FD&C BLUE NO. 1(UNII: H3R47K3TBD)
FD&C BLUE NO. 2(UNII: L06K8R7DQK)
Product Characteristics
Color blue Score 2 pieces
Shape CAPSULE Size 10 mm
Flavor Imprint Code G;75
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0615-8486-3930 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
2NDC:0615-8486-0515 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
3NDC:0615-8486-306 in 1 BOX, UNIT-DOSE 11/07/2023
35 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078403 05/15/2023
Sertraline hydrochlorideSertraline hydrochloride TABLET, FILM COATED
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0615-8487(NDC:70010-205)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SERTRALINE HYDROCHLORIDE(UNII: UTI8907Y6X)
(SERTRALINE - UNII:QUC7NX6WMB) 		SERTRALINE100 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE(UNII: ETJ7Z6XBU4)
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS(UNII: L11K75P92J)
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED(UNII: 2165RE0K14)
MAGNESIUM STEARATE(UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE(UNII: OP1R32D61U)
SODIUM STARCH GLYCOLATE TYPE A(UNII: H8AV0SQX4D)
TALC(UNII: 7SEV7J4R1U)
HYPROMELLOSE 2910 (5 MPA.S)(UNII: R75537T0T4)
POLYETHYLENE GLYCOL 400(UNII: B697894SGQ)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
D&C YELLOW NO. 10(UNII: 35SW5USQ3G)
FERRIC OXIDE YELLOW(UNII: EX438O2MRT)
Product Characteristics
Color yellow Score 2 pieces
Shape CAPSULE Size 12 mm
Flavor Imprint Code G;76
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0615-8487-3930 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
2NDC:0615-8487-0515 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
3NDC:0615-8487-306 in 1 BOX, UNIT-DOSE 11/03/2023
35 in 1 BLISTER PACK Type 0: Not a Combination Product16/08/2023
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078403 05/15/2023

LABELER - NCS HealthCare of KY, LLC dba Vangard Labs(050052943)

Establishment
Name Address ID/FEI Business Operations
NCS HealthCare of KY, LLC dba Vangard Labs 050052943 repack(0615-8485, 0615-8486, 0615-8487)

PRINCIPAL DISPLAY PANEL

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Principal Display Panel

PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL

Principal Display Panel

PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL